Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers

Simple item page
dc.contributor.authorLe Page, Cécile
dc.contributor.authorRahimi, Kurosh
dc.contributor.authorKöbel, Martin
dc.contributor.authorTonin, Patricia N
dc.contributor.authorMeunier, Liliane
dc.contributor.authorPortelance, Lise
dc.contributor.authorBernard, Monique
dc.contributor.authorNelson, Brad H
dc.contributor.authorBernardini, Marcus Q
dc.contributor.authorBartlett, John M S
dc.contributor.authorBachvarov, Dimcho
dc.contributor.authorGotlieb, Walter H
dc.contributor.authorGilks, Blake
dc.contributor.authorMcAlpine, Jessica N
dc.contributor.authorNachtigal, Mark W
dc.contributor.authorPiché, Alain
dc.contributor.authorWatson, Peter H
dc.contributor.authorVanderhyden, Barbara
dc.contributor.authorHuntsman, David G
dc.contributor.authorProvencher, Diane M
dc.contributor.authorMes-Masson, Anne-Marie
dc.date.accessioned2018-09-26T12:01:20Z
dc.date.available2018-09-26T12:01:20Z
dc.date.issued2018-03-27
dc.date.updated2018-09-26T12:01:20Z
dc.description.abstractAbstract Background Ovarian carcinoma is the most lethal gynecological malignancy due to early dissemination and acquired resistance to platinum-based chemotherapy. Reliable markers that are independent and complementary to clinical parameters are needed to improve the management of patients with this disease. The Canadian Ovarian Experimental Unified Resource (COEUR) provides researchers with biological material and associated clinical data to conduct biomarker validation studies. Using standards defined by the Canadian Tissue Repository Network (CTRNet), we have previously demonstrated the quality of the biological material from this resource. Here we describe the clinical characteristics of the COEUR cohort. Methods With support from 12 Canadian ovarian cancer biobanks in Canada, we created a central retrospective cohort comprised of more than 2000 patient tissue samples with associated clinical data, including 1246 high-grade serous, 102 low-grade serous, 295 endometrioid, 259 clear cell and 89 mucinous carcinoma histotypes. A two-step reclassification process was applied to assure contemporary histological classification (histotyping). For each histotypes individually, we evaluated the association between the known clinico-pathological parameters (stage, cytoreduction, chemotherapy treatment, BRCA1 and BRCA2 mutation) and patient outcome by using Kaplan-Meier and Cox proportional hazard regression analyses. Results The median follow-up time of the cohort was 45 months and the 5-year survival rate for patients with high-grade serous carcinomas was 34%, in contrast to endometrioid carcinomas with 80% at 5 years. Survival profiles differed by histotype when stratified by stage or cytoreduction. Women with mucinous or clear cell carcinomas at advanced stage or with non-optimally debulked disease had the worst outcomes. In high-grade serous carcinoma, we observed significant association with longer survival in women harboring BRCA1 or BRCA2 mutation as compared to patients without detectable mutation. Conclusions Our results show the expected survival rates, as compared with current literature, in each histotype suggesting that the cohort is an unbiased representation of the five major histotypes. COEUR, a one stop comprehensive biorepository, has collected mature outcome data and relevant clinical data in a comprehensive manner allowing stratified analysis.
dc.identifier.citationBMC Cancer. 2018 Mar 27;18(1):347
dc.identifier.doihttps://doi.org/10.1186/s12885-018-4242-8
dc.identifier.urihttp://hdl.handle.net/1880/107881
dc.language.rfc3066en
dc.rights.holderThe Author(s).
dc.titleCharacteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers
dc.typeJournal Article
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
12885_2018_Article_4242.pdf
Size:
1.34 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Publications